Suppression of Mig-6 overcomes the acquired EGFR-TKI resistance of lung adenocarcinoma

BACKGROUND: The resistance of lung cancer to epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) is one of the unconquered frontiers in chemotherapy. Mitogen-inducible gene 6 (Mig-6) is known to inhibit the kinase activity of epidermal growth factor receptor (EGFR). Similarly, nume...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cancer
Main Authors: Kang, Da Hyun, Jung, Sung Soo, Yeo, Min-Kyung, Lee, Da Hye, Yoo, Geon, Cho, Sang Yeon, Oh, In-Jae, Kim, Ju-Ock, Park, Hee Sun, Chung, Chaeuk, Lee, Jeong Eun
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2020
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7302243/
https://ncbi.nlm.nih.gov/pubmed/32552717
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-020-07057-z
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados